Showing results (71-80 of 173) with videos related to
Sort By:
Pageof 18
Leukemia & Lymphoma|August 5, 2011
Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemiaClive S Zent, Brian J Smith, Zuhair K Ballas, et al.Clinical Lymphoma, Myeloma & Leukemia|October 1, 2015
Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center ExperienceMoussab Damlaj, Nanna H Sulai, Jennifer L Oliveira, et al.Cancer Genetics and Cytogenetics|June 2, 2006
Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemiaStephanie R Fink, Stephanie A Smoley, Kimberly J Stockero, et al.Leukemia & Lymphoma|December 12, 2022
Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selectionKurt S Bantilan, Neil E Kay, Sameer A Parikh, et al.British Journal of Haematology|April 4, 2008
Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemiaShanique Palmer, Curtis A Hanson, Clive S Zent, et al.British Journal of Haematology|October 4, 2007
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemiaKami Maddocks-Christianson, Susan L Slager, Clive S Zent, et al.British Journal of Haematology|April 7, 2009
Risk of non-Hodgkin lymphoma in association with germline variation in complement genesJames R Cerhan, Anne J Novak, Zachary S Fredericksen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemiaGrzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, et al.International Journal of Cancer|November 1, 2011
Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphomaShernan G Holtan, Helen M O'Connor, Zachary S Fredericksen, et al.Cytometry. Part B, Clinical Cytometry|June 23, 2010
CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entityRoxana S Dronca, Dragan Jevremovic, Curtis A Hanson, et al.Pageof 18